Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

High Throughput PCR Plate Preparation

By Drug Discovery Trends Editor | November 14, 2008

Velocity11 PCR WorkstationVelocity11 released a technical note describing an automated Polymerise Chain Reaction (PCR) workstation based upon a combination of their Bravo liquid handler, BenchCel plate handling system, PlateLoc thermal microplate sealer and a bulk reagent dispenser.

The automated workstation is shown to provide a reliable, efficient solution for processing plates in batches or one at a time through the necessary stages of PCR plate preparation. Using the described protocol up to 50 diluted replicate plates with Master Mix and Exon additions can be run without user intervention.

The on-deck accessories for the Bravo liquid handler are shown to provide the temperature control and sonicating wash to decontaminate tips that are necessary capabilities for working with DNA and other sensitive materials. Velocity 11’s VWorks automation control software was used to provide a single, simple user interface to control all critical task parameters.

The combination of Velocity11’s Bravo liquid handler, BenchCel plate handling system, PlateLoc thermal microplate sealer, and a bulk reagent dispenser is shown to allow users to run the PCR preparation with high throughput and maximum walk-away time. 

Velocity11 


Filed Under: Drug Discovery

 

Related Articles Read More >

TransCelerate CEO Janice Chang wants trials to become part of routine care
STEERLife’s FragMelt platform manufactures drugs with heat sensitive active ingredient 
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE